Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
19,803,074
-
Share change
-
-844,267
-
Total reported value
-
$102,381,000
-
Put/Call ratio
-
70%
-
Price per share
-
$5.17
-
Number of holders
-
45
-
Value change
-
-$3,698,549
-
Number of buys
-
16
-
Number of sells
-
23
Institutional Holders of AC Immune SA - SHS (ACIU) as of Q4 2020
As of 31 Dec 2020,
AC Immune SA - SHS (ACIU) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,803,074 shares.
The largest 10 holders included
BVF INC/IL, Temasek Holdings (Private) Ltd, EcoR1 Capital, LLC, Artal Group S.A., ACADIAN ASSET MANAGEMENT LLC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, WELLS FARGO & COMPANY/MN, Verition Fund Management LLC, and Tekla Capital Management LLC.
This page lists
45
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.